Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor sperm use, or ovulation conditions that respo - facebook.com
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor …
Published: Nov. 10, 2025, 3:02 p.m.
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor sperm use, or ovulation conditions that respo - Facebook
Who should consider IUI? IUI (intrauterine insemination) may be a helpful option in a variety of situations, including mild male factor infertility, cervical mucus issues, unexplained infertility, mild endometriosis, donor …
Published: Nov. 10, 2025, 3:02 p.m.
Integrated Bioinformatics and Experimental Analysis Revealed Crosstalk Between IL-6, Autophagy, Ubiquitination, and Key miRNAs in Female Infertility: Insights from Ovarian Endometriosis and Polycystic Ovary Syndrome.
Female infertility, affecting millions worldwide, involves complex molecular mechanisms such as chronic inflammation, impaired cellular death, and protein regulation. This study explores how the cytokine IL-6, the autophagy marker LC3, …
Published: Oct. 28, 2025, midnight
Understanding Peritoneal Fluid Estrogen and Progesterone Concentrations Permits Individualization of Medical Treatment of Endometriosis-Associated Pain with Lower Doses, Especially in Adolescents Not Requiring Contraception.
Objectives: The aim of this study was to review the importance of peritoneal fluid steroid hormone concentrations to understand the mechanism of hormonal medical treatment of endometriosis-associated pain. Design: The …
Published: Oct. 12, 2025, midnight
Impact of endocrine disruptors on female fertility: an update.
Endocrine disruptors (EDs) are a heterogeneous group of natural or synthetic chemicals capable of interfering with hormonal regulation. Widely present in plastics, cosmetics, pesticides, food packaging, and household products, they …
Published: Oct. 7, 2025, midnight
From menses to ovulation: the immunomodulatory role of monocyte cytokines in menstrual cycle physiology and reproductive health - a narrative review.
Monocytes, as essential components of the immune system, play a pivotal role in regulating immune responses throughout the menstrual cycle. Their cytokine secretion is integral to immune modulation, influencing processes …
Published: Oct. 7, 2025, midnight
Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment.
Endometriosis is characterized by the presence of endometrial tissue outside the uterine cavity. The administration of drugs designated for this condition has significant adverse effects, such as signs of estrogen …
Published: Sept. 12, 2025, midnight
Ultrahuman and viO team up for revolutionary cycle & ovulation tracking feature - MSN
Ultrahuman and viO team up for revolutionary cycle & ovulation tracking feature MSN
Published: Aug. 31, 2025, 2:31 p.m.
Natural Pregnancy Following Oocyte Retrieval in a Luteal-Phase Progestin-Primed Ovarian Stimulation (PPOS) Protocol With Concurrent Blastocyst Cryopreservation: A Case Report.
Ovarian stimulation is used in assisted reproductive technology to help infertile couples achieve pregnancy. Luteal-phase stimulation with progestin-primed ovarian stimulation (PPOS) is a practical approach, as it involves oral medication …
Published: Aug. 17, 2025, midnight
Ultrahuman Enhances Women's Health Tracking with Acquisition of viO HealthTech and New Cycle & Ovulation Pro Feature - SSBCrack
Ultrahuman Enhances Women's Health Tracking with Acquisition of viO HealthTech and New Cycle & Ovulation Pro Feature SSBCrack
Published: Aug. 16, 2025, 1:14 a.m.